Year To Quarter End Consolidated Statement Of Comprehensive Income

Mochida Pharmaceutical Co.,Ltd. - Filing #7353503

Concept 2023-04-01 to
2023-12-31
2022-04-01 to
2022-12-31
Year to quarter end consolidated statement of comprehensive income
Statement of comprehensive income
Profit (loss)
4,444,000,000 JPY
8,081,000,000 JPY
Other comprehensive income
Valuation difference on available-for-sale securities
2,126,000,000 JPY
-993,000,000 JPY
Remeasurements of defined benefit plans, net of tax
-34,000,000 JPY
-32,000,000 JPY
Other comprehensive income
2,092,000,000 JPY
-1,026,000,000 JPY
Comprehensive income
6,536,000,000 JPY
7,055,000,000 JPY
Comprehensive income attributable to
Comprehensive income attributable to owners of parent
6,536,000,000 JPY
7,055,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.